| 000 | 01169 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250512010001.0 | ||
| 264 | 0 | _c19900215 | |
| 008 | 199002s 0 0 ger d | ||
| 022 | _a0303-8408 | ||
| 024 | 7 |
_a10.1007/BF02083222 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHannig, M | |
| 245 | 0 | 0 |
_a[Surveillance and assessment of undesirable effects in drug treatment: pilot project]. _h[electronic resource] |
| 260 |
_bSozial- und Praventivmedizin _c1989 |
||
| 300 |
_a272-7 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article | ||
| 650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadverse effects |
| 650 | 0 | 4 | _aDocumentation |
| 650 | 0 | 4 | _aDrug-Related Side Effects and Adverse Reactions |
| 650 | 0 | 4 | _aFamily Practice |
| 650 | 0 | 4 | _aGermany, West |
| 650 | 0 | 4 |
_aHistamine H2 Antagonists _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aProduct Surveillance, Postmarketing |
| 700 | 1 | _aHanpft, R | |
| 773 | 0 |
_tSozial- und Praventivmedizin _gvol. 34 _gno. 6 _gp. 272-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF02083222 _zAvailable from publisher's website |
| 999 |
_c2581251 _d2581251 |
||